Last reviewed · How we verify
NCT05250947
Study Evaluating the Safety and Feasibility of Platelet-rich Plasma to Treat Facetogenic Low Back Pain
Phase 1 trial testing Angel® Concentrated Platelet Rich Plasma System in Lumbar Spondylosis in 4 participants. Terminated before completion.
20 May 2024
Quick facts
| Lead sponsor | Matthew Pingree |
|---|---|
| Phase | Phase 1 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 4 |
| Start date | 5 January 2023 |
| Primary completion | 20 May 2024 |
| Estimated completion | 20 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Angel® Concentrated Platelet Rich Plasma System
- Platelet Rich Plasma — full drug profile →
Conditions studied
- Lumbar Spondylosis — all drugs for Lumbar Spondylosis →
Sponsor
Matthew Pingree
Who can join
Adults 22 to 70, any sex, with Lumbar Spondylosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is being done to assess the safety of using the Angel Concentrated Platelet Rich Plasma System to process Platelet Rich Plasma (PRP) to treat arthritis of the low back (lumbar spondylosis).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05250947
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lumbar Spondylosis
Currently open trials in the same condition.
- NCT06477094 — RFA Using Multi-Tined Electrodes vs.Traditional Electrodes for Lumbar Spondylosis · NA · recruiting
- NCT05029726 — Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05250947 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Matthew Pingree
- Last refreshed: 17 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05250947.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing